U.S. markets open in 6 hours 36 minutes
  • S&P Futures

    3,665.75
    -1.50 (-0.04%)
     
  • Dow Futures

    29,858.00
    -10.00 (-0.03%)
     
  • Nasdaq Futures

    12,474.00
    +19.75 (+0.16%)
     
  • Russell 2000 Futures

    1,835.20
    -2.30 (-0.13%)
     
  • Crude Oil

    45.33
    +0.05 (+0.11%)
     
  • Gold

    1,843.70
    +13.50 (+0.74%)
     
  • Silver

    24.29
    +0.21 (+0.87%)
     
  • EUR/USD

    1.2124
    +0.0009 (+0.07%)
     
  • 10-Yr Bond

    0.9480
    0.0000 (0.00%)
     
  • Vix

    21.17
    +0.40 (+1.93%)
     
  • GBP/USD

    1.3398
    +0.0023 (+0.17%)
     
  • USD/JPY

    104.3070
    -0.1170 (-0.11%)
     
  • BTC-USD

    19,221.53
    +140.18 (+0.73%)
     
  • CMC Crypto 200

    376.80
    +11.89 (+3.26%)
     
  • FTSE 100

    6,463.39
    +78.66 (+1.23%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

Lux Health Tech Acquisition Corp. Announces Pricing of $300 Million Initial Public Offering

·3 min read

Lux Health Tech Acquisition Corp. (the "Company") announced today the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Stock Market, LLC ("Nasdaq") and will trade under the ticker symbol "LUXAU" beginning on October 27, 2020. Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-third of one warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at an exercise price of $11.50 per share. After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols "LUXA" and "LUXAW," respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade.

Credit Suisse Securities (USA) LLC is acting as sole book-running manager for the offering and Stifel, Nicolaus & Company, Incorporated is acting as lead manager. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

The offering is being made only by means of a prospectus. Copies of the prospectus may be obtained, when available, from Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, 6933 Louis Stephens Drive, Morrisville, North Carolina 27560, United States, Telephone: 1-800-221-1037, Email: usa.prospectus@credit-suisse.com.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission ("SEC") and became effective on October 26, 2020. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Lux Health Tech Acquisition Corp.

Lux Health Tech Acquisition Corp. is a blank check company sponsored by an affiliate of Lux Capital and formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses at the intersection of the healthcare and technology industries.

Forward-Looking Statements

This press release contains statements that constitute "forward-looking statements," including with respect to the Company’s initial public offering. No assurance can be given that the offering will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005925/en/

Contacts

Investors:
Scott Rubin
scott.rubin@luxcapital.com